ライブラリ登録: Guest
Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集
Critical Reviews™ in Immunology
インパクトファクター: 1.352 5年インパクトファクター: 3.347 SJR: 0.657 SNIP: 0.55 CiteScore™: 2.19

ISSN 印刷: 1040-8401
ISSN オンライン: 2162-6472

巻:
巻 39, 2019 巻 38, 2018 巻 37, 2017 巻 36, 2016 巻 35, 2015 巻 34, 2014 巻 33, 2013 巻 32, 2012 巻 31, 2011 巻 30, 2010 巻 29, 2009 巻 28, 2008 巻 27, 2007 巻 26, 2006 巻 25, 2005 巻 24, 2004 巻 23, 2003 巻 22, 2002 巻 21, 2001 巻 20, 2000 巻 19, 1999 巻 18, 1998 巻 17, 1997 巻 16, 1996 巻 15, 1995 巻 14, 1994

Critical Reviews™ in Immunology

DOI: 10.1615/CritRevImmunol.v21.i1-3.190
11 pages

Quantitating Therapeutically Relevant T-Cell Responses to Cancer Vaccines

Amy C. Hobeika
Department of Surgery, Duke University Medical Center
Timothy M. Clay
Department of Surgery, Duke University Medical Center
Paul J. Mosca
Departments of Surgery, Duke University Medical Center
H. Kim Lyerly
Departments of Surgery, Pathology, and Immunology, Duke University Medical Center
Michael A. Morse
Department of 2Medicine, Duke University Medical Center

要約

Successful application of active immunotherapy to the treatment of cancer will require stimulation of potent antigen-specific T-cell responses. It is not known how numerous or how potent these T cells must be in order to abrogate tumors, but the levels of immunity needed to control chronic viral infections may provide estimates for comparison. Evaluation of the efficacy of a vaccine strategy in attaining these levels of immunity will depend on the use of assays that create a picture of T-cell number and function that correlates with clinical outcomes. We discuss the currently available in vivo and in vitro T-cell assays and their relevance for detecting therapeutic levels of T-cell activity. We also propose a strategy for efficiently evaluating the immunologic efficacy of cancer vaccines so that the most promising candidates can be brought more rapidly into definitive clinical trials.


Articles with similar content:

Clinical and Experimental Sepsis Impairs CD8 T-Cell-Mediated Immunity
Critical Reviews™ in Immunology, Vol.36, 2016, issue 1
Robert K. Strother, Derek B. Danahy, Thomas S. Griffith, Vladimir P. Badovinac
Stem Cells for Skin Tissue Engineering and Wound Healing
Critical Reviews™ in Biomedical Engineering, Vol.37, 2009, issue 4-5
Francois Berthiaume, Melissa Przyborowski, Ming Chen
Regulatory T-Cell Therapy in Transplantation and Severe Autoimmunity
Critical Reviews™ in Immunology, Vol.35, 2015, issue 6
Roberto Spreafico, Maura Rossetti
Chemopreventive and Tumoricidal Properties of Ling Zhi Mushroom Ganoderma lucidum (W.Curt.: Fr.)Lloyd (Aphyllophoromycetideae). Part II. Mechanism Considerations (Review)
International Journal of Medicinal Mushrooms, Vol.6, 2004, issue 3
Yihuai Gao, Shufeng Zhou
Chlamydia pneumoniae Infection and Inflammatory Diseases
Forum on Immunopathological Diseases and Therapeutics, Vol.7, 2016, issue 3-4
Timothy R. Crother, Rebecca A. Porritt